Respiratory care practitioner took controlled dang…

What Happened

The Maryland Board of Physicians found that a respiratory care practitioner took controlled dangerous substances from her workplace.

She was reprimanded with terms and conditions upon applying for reinstatement.

What the Record Shows

reprimand with terms and conditions, upon applying for reinstatement

Why It Matters for Diversion Programs

This entry comes from a primary source rather than a federal enforcement release, and it is recorded as reported: found to have taken controlled dangerous substances from her workplace. Board and news records are a lagging indicator - by the time a licensing authority or a reporter learns of a diversion, the diversion was normally detected internally first, which makes each entry a signal that inventory reconciliation, waste observation or dispensing oversight failed earlier.

Sources

https://www.mbp.state.md.us/forms/fall2011.pdf

Case at a Glance

Setting: Workplace
Drug: controlled dangerous substances
Method: found to have taken controlled dangerous substances from her workplace
Status: reprimand with terms and conditions, upon applying for reinstatement

Primary source: https://www.mbp.state.md.us/forms/fall2011.pdf

Share: LinkedIn X Facebook

Last reviewed: September 2026 · Educational content, not legal advice.

About the author

DivertGuard is built and maintained by Alex Rodriguez, MHIIM, CPhT (also known as Jesus Rodriguez) — a healthcare compliance analytics professional with more than a decade in pharmacy practice and direct responsibility for a health-system controlled substance diversion prevention program.

IHFDA Annual Conference presentations

2025 — The Rounding Revolution: A High-Tech Approach to Diversion Prevention (with Emily Spiceland, PharmD)
2024 — No Pill Left Behind: Strategies for Comprehensive Drug Accountability (with Eric Andrews)
2022 — Ready for My Close Up! Implementing, Maintaining, and Expanding Drug Diversion Prevention Cameras (with Jeremy Quinn, Shawn Young, and John Bailey)

Other professional engagement

Faculty, ASHP Drug Diversion Certificate
Speaker, Health Care Compliance Association (HCCA)
Published author, Pharmacy Purchasing & Products

Credentials

MHIIM — Master of Health Informatics and Information Management, University of Tennessee Health Science Center (2019–2021)
CPhT — Certified Pharmacy Technician, with 10+ years of pharmacy practice across retail, hospice, compounding, home-health, and hospital settings

The assessment items, weighting, and case registry behind this site come from that operational background — building and running a diversion prevention program, not from vendor marketing. Every tool here is free, requires no signup, and is based on published regulatory and professional standards (DEA, Joint Commission, ASHP, CDC).

Full author bio and credentials →

Related Resources

Diversion Settlements & Fines

Settlements, civil penalties and criminal fines paid by hospitals and pharmacies in documented drug diversion cases, with the amount, year and primary source for each

Drug Diversion Statistics

Charts and data tables from 716 documented federal and state cases — drugs, settings, outcomes, and cases by year

Prevention Value Deck (Download)

Free 10-slide PowerPoint that makes the case for a diversion prevention program — documented penalties, deaths and how to evidence your own value, every figure cited

Respiratory care practitioner took controlled dangerous substances from her workplace